NRG-CC009 for Brain Mets from SCLC with Dr. Vinai Gondi episode artwork

EPISODE · May 2, 2025 · 33 MIN

NRG-CC009 for Brain Mets from SCLC with Dr. Vinai Gondi

from The NRG Oncology Podcast · host NRG Oncology

NRG Oncology Podcast co-hosts talk with Dr. Vinai Gondi, the Principal Investigator of the NRG-CC009 phase III clinical study assessing stereotactic radiosurgery (SRS) versus hippocampal-avoidant whole brain radiotherapy (HA-WBRT) for patients who have brain metastases (or cancer that has spread to the brain) from their small cell lung cancer (SCLC).

NRG Oncology Podcast co-hosts talk with Dr. Vinai Gondi, the Principal Investigator of the NRG-CC009 phase III clinical study assessing stereotactic radiosurgery (SRS) versus hippocampal-avoidant whole brain radiotherapy (HA-WBRT) for patients who have brain metastases (or cancer that has spread to the brain) from their small cell lung cancer (SCLC).

NOW PLAYING

NRG-CC009 for Brain Mets from SCLC with Dr. Vinai Gondi

0:00 33:13

No transcript for this episode yet

We transcribe on demand. Request one and we'll notify you when it's ready — usually under 10 minutes.

Frequently Asked Questions

How long is this episode of The NRG Oncology Podcast?

This episode is 33 minutes long.

When was this The NRG Oncology Podcast episode published?

This episode was published on May 2, 2025.

What is this episode about?

NRG Oncology Podcast co-hosts talk with Dr. Vinai Gondi, the Principal Investigator of the NRG-CC009 phase III clinical study assessing stereotactic radiosurgery (SRS) versus hippocampal-avoidant whole brain radiotherapy (HA-WBRT) for patients who...

Can I download this The NRG Oncology Podcast episode?

Yes, you can download this episode by clicking the download button on the episode player, or subscribe to the podcast in your preferred podcast app for automatic downloads.
URL copied to clipboard!